Summary of Purpose
The Purpose of this open-label randomized controlled multicenter trial is to evaluate the efficacy and safety of mono-drug therapy with oral anticoagulant compared to combination therapy with antiplatelet drug, in ischemic stroke patients with non-valvular atrial fibrillation and atherothrombosis.Read More →
The following dates are available for this trial. Trial information last updated on 22 December 2017.
|6 Apr 2017||8 Feb 2017||31 Jan 2021||31 Jan 2021||1 Dec 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Hiroshi Yamagami, MD
- Shuhei Okazaki, MD